With more than 15 years of contract manufacturing experience, LuinaBio scientists have the background and expertise to produce successful outcomes for any biomanufacturing product. This experience has included small molecule synthesis with a particular depth of experience in carbohydrate chemistry suitable for product development in pre-clinical and phase 1 to 3 human clinical trials and commercially marketed human and veterinary products for clients in Australia, New Zealand, North America and Asia.
LuinaBio can use this knowledge and understanding of small molecule synthesis to help develop a scalable process that meets the highest standards at all stages of your product’s lifecycle. Our range of services includes carbohydrates, carbohydrate conjugates and synthetic molecules that are highly cost competitive.
We maintain a focus on the larger picture in the development process. Tight budgets and even tighter timelines can push for a minimisation of standards to meet project deadlines and milestones. Our fast access and turnaround times provide ease and flexibility without sacrificing quality.
Our TGA/APVMA licensed facilities operate to international GMP standards and can provide comprehensive and innovative manufacturing solutions for your small molecule products. Its equipment allows LuinaBio to synthesize small batches in cGMP and to modify the molecules produced by fermentation.